Obat Off-Label Pada Anak di Pelayanan Rawat Jalan Klinik Pratama Swasta Kabupaten Sleman Yogyakarta

Ndaru Setyaningrum; Haudatul Khamsani; Rosita Mulyawati

doi:10.25077/jsfk.6.1.37-45.2019

Obat Off-Label Pada Anak di Pelayanan Rawat Jalan Klinik Pratama Swasta Kabupaten Sleman Yogyakarta

Ndaru Setyaningrum, Haudatul Khamsani, Rosita Mulyawati

10.25077/jsfk.6.1.37-45.2019

Abstrak

Penelitian ini dilakukan untuk mengetahui peresepan obat off label pada anak di pelayanan rawat jalan klinik pratama swasta di Kabupaten Sleman. Penelitian dilakukan secara retrospektif dengan pengambilan data berdasarkan rekam medis anak tahun 2015. Subjek penelitian merupakan rekam medis anak dengan batasan usia di bawah 11 tahun. Jumlah populasi selama periode penelitian adalah 119 rekam medis. Total jumlah penggunaan obat sebanyak 343 obat. Hasil kajian penggunaan obat off-label ditemukan 107 kasus (31,19%). Kategori obat off-label berturut – turut dari prevalensi tertinggi adalah off-label dosis 53 kasus (15,45%); off-label usia 40 kasus (11,66%); off-label indikasi 13 kasus (3,79%); dan off-label cara pemberian 1 (0,29%). Rentang usia anak 1 – 23 bulan ditemukan off-label sebanyak 14 anak (11,76%); usia 2 - <5 tahun dan 5 – 11 tahun masing – masing 38 anak (31,92%). Jenis obat off-label paling dominan adalah klorfeniramin maleat kategori subdosis dan off-label usia. Hasil penelitian ini mendorong perhatian lebih tenaga kesehatan terhadap efikasi dan risiko penggunaan obat off-label pada anak

Kata Kunci

off-label; peresepan; anak; klinik pratama swasta

Teks Lengkap:

PDF

Referensi

Oguz SS, Kanmaz HG, Dilmen U, 2012. Off-label and unlicensed drug use in neonatal intensive care units in Turkey: the old-inn study. International Journal of Clinical Pharmacy 34:(1) 136–141.

Knopf, H., Wolf, I-K., Sarganas, G., Zhuang, W., Rascher, W., Neubert, A., 2013, Off-label medicine use in children and adolescent: result of a population based study in Germany. BMC Public Health, 13:631.

Palmaro A, Bissuel R, Renaud N, Durrieu G, Escourrou B, Oustric S, et al. Off-Label Prescribing in Pediatric Outpatients. Pediatrics. 1 Januari 2015 ; 135(1) : 49–58.

Perez, R.P., Antoran, A.B.R., Sola, C.A., Riechmann, E.R., Garcia, L.C., Ortega, M.J.C., Pena, M.J.M., 2014, Result from 2012-2013 Paediatric National Survey on Off-Label Drug Use in Children in Spain, An Pediatr(Barc), 81(1):16-21.

Pratiwi, A.A., Khairinnisa, M.A., Alfian, S.D., Priyadi, A., Pradipta, I.S., Abdulah, R., 2013, Peresepan Obat-obat Off-Label pada Pasien Anak Usia 0 Hingga 2 Tahun di Apotek Kota Bandung. Jurnal Farmasi Klinik Indonesia;2(2):39-50.

Setyaningrum, N., Gredynadita, V., Gartina, S., 2017, Penggunaan Obat Off-Label pada Anak di Apotek Kota Yogyakarta, Jurnal Sains Farmasi & Klinis, 4(2), 30–35.

Gonc¸alves, MG, Heineck I. Frequency of prescriptions of off-label drugs and drugs not approved for pediatric use in primary health care in a southern municipality of Brazil, Rev Paul Pediatr. 2016;34(1):11---17

Jung K, LePendu P, Chen WS, Iyer SV, Readhead B, Dudley JT, et al. Automated Detection of Off-Label Drug Use. PloS One. 2014; 9(2) : e89324.

Wittich CM, Burkle CM, Lanier WL. Ten Common Questions (and Their Answers) About Off-label Drug Use. Mayo Clin Proc. Oktober 2012; 87(10) : 982–990.

Bavdekar, B.S., Sadawarte, P.A., Gogtay, N.J., Jain, S.S., Jadhav, S., 2009, Off-Label Drug Use in a Pediatric Intensive Care Unit. The Indian Journal of Pediatrics, 76(11):1113-1118)

Winarni., Nur Salim Safrudin., Al Ummah Basirun., 2010. Hubungan Antara Perilaku Merokok Orang Tua dan Anggota Keluarga Yang Tinggal Dalam Satu Rumah dengan Kejadian ISPA Pada Balita di Wilayah Kerja Puskesmas Sempor II Kabupaten Kebumen Tahun 2009.

Sharma, D., Kuppusamy, K., Bhoorasamy, A. (2013). Prevalence of Acute Respiratory Infections (ARI) and their determinants in under five children in urban and rural areas of Kancheepuram District, South India, Annals of Tropical Medicine and Public Health 6:5.

Marhamah., A., Arsunan Arsin., Wahiduddin., 2012. Faktor Yang Berhubungan Dengan Kejadian ISPA Pada Anak Balita di Desa Bontongan Kabupaten Enrekang.

Tazinya, A.A., Halle-Ekane, G.E., Mbuagbaw, L.T., Abanda, M., Atashili, J., Obama, M.T. Risk factors for acute respiratory infections in children under five years attending the Bamenda Regional Hospital in Cameroon. BMC Pulmonary Medicine (2018) 18:7.

Yawn, J., Lawrence, L.A., Carroll, W.W., Mulligan, J.K., Vitamin D for the treatment of respiratory diseases: Is it the end or just the beginning? The Journal of Steroid Biochemistry and Molecular Biology (2015) 148:326-337

de Martino M, Chiarugi A. Recent Advances in Pediatric Use of Oral Paracetamol in Fever and Pain Management. Pain Ther (2015) 4:149–168.DOI 10.1007/s40122-015-0040-z

Kigen G, Busakhala N, Ogaro F, Chesire E, Saat N, Too R, etal. (2015) A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants? PLoSONE10(11):e0142092. doi:10.1371/journal.pone.0142092.

. Fitzsimons, R., Van Der Poel, L. A., Thornhill, W., Du Toit, G., Shah, N., & Brough, H. A. (2015). Antihistamine use in children. Archives of Disease in Childhood: Education and Practice Edition, 100(3), 122–131. https://doi.org/10.1136/archdischild-2013-304446

Simon C, Martin T, David A,. (2016) It is time to stop prescribing oral salbutamol. Australian Family Physician45:4.

Bonner S, Matte T, Rubin M, Fagan J.K., Ahern J. & Evans D,. (2009) Oral β2-Agonist Use by Preschool Children with Asthma in East and Central Harlem, New York, Journal of Asthma, 43:1, 31-35

Littenberg, Benjamin, et al. "A randomized controlled trial of oral albuterol in acute cough." Journal of Family Practice, Jan. 1996, p. 49+. Academic OneFile, Accessed 27 Mar. 2018.

Matera MG, Rogliani P, Zanasi A, Cazzola M. Bronchodilator therapy for chronic cough. Pulmonary Pharmacology & Therapeutics 47 (2017) 88e92.

Joint Formulary Committe. British National Formulary. London: RPS Publishing; 2015.

Akbar, R., Setyaningrum, N., & Estiningsih, D. (2017). Kajian penggunaan obat off-label pada anak di Puskesmas Sleman. INPHARNMED Journal,1(1), 21-33.

DOI: https://doi.org/10.25077/jsfk.6.1.37-45.2019